1276P Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): Real-world 3-year outcomes within overall and special populations (the UNIVOC study)

J-B. Assié, R. Corre, Matteo Giaj Levra et al. · Annals of Oncology · 2020

Cited by 1 works. doi:10.1016/j.annonc.2020.08.1590 Open-access PDF

Authors

References